- Can't tell
You should not use this medication if you are allergic to olopatadine.
Before using olopatadine ophthalmic, tell your doctor if you have any type of infection in your eye.
FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.
It is not known whether olopatadine ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
Do not use this medication in a child younger than 3 years old without the advice of a doctor.
Do not use olopatadine ophthalmic while you are wearing contact lenses. Olopatadine ophthalmic may contain a preservative that can be absorbed by soft contact lenses. Wait at least 10 minutes after using olopatadine before putting your contact lenses in.
Avoid wearing contact lenses while your eyes are red or irritated.
Avoid using other eye medications not prescribed by your doctor.
Seek emergency medical attention if you think you have used too much of this medicine.
An overdose of olopatadine ophthalmic is not likely to cause life-threatening symptoms.
Use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using olopatadine ophthalmic and call your doctor at once if you have severe redness, swelling, burning, stinging, drainage, crusting, or other irritation when using the eye drops.
Less serious side effects may include:
- mild burning, stinging, irritation, itching, redness, or dryness of the eyes;
- blurred vision;
- feeling that something is in your eye;
- puffy eyelids;
- stuffy or runny nose, cough, sore throat;
- back pain;
- headache; or
- unusual or unpleasant taste in your mouth.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with olopatadine ophthalmic. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
Pataday, Patanol, and olopatadine ophthalmic
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04